18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial-Reference-Cited by-同舟云学术

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

Published:2014-02 Issue:9918 Volume:383 Page:705-713
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Joshi Nikhil V,Vesey Alex T,Williams Michelle C,Shah Anoop S V,Calvert Patrick A,Craighead Felicity H M,Yeoh Su Ern,Wallace William,Salter Donald,Fletcher Alison M,van Beek Edwin J R,Flapan Andrew D,Uren Neal G,Behan Miles W H,Cruden Nicholas L M,Mills Nicholas L,Fox Keith A A,Rudd James H F,Dweck Marc R,Newby David E

Funder

Chief Scientist Office, Scotland

British Heart Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I;Naghavi;Circulation,2003

2. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions;Virmani;Arterioscler Thromb Vasc Biol,2000

3. Pathology of the vulnerable plaque;Virmani;J Am Coll Cardiol,2006

4. Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles;Rogers;Curr Cardiol Rep,2011

5. The vascular biology of atherosclerosis and imaging targets;Libby;J Nucl Med,2010

Cited by 806 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Comparison of Progression of Atherosclerotic Plaques and Calcification of Coronary Artery in Atrial Fibrillation Patients Treated With Edoxaban Versus Warfarin (The REPRESENT-AF trial);The American Journal of Cardiology;2024-10

2. Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial;Journal of the American Heart Association;2024-09-09

3. Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases;Nature Reviews Rheumatology;2024-09-02

4. Molecular imaging of coronary plaque vulnerability using 18F- fluorocholine PET-MRI in patients with coronary artery disease: validation with optical coherence tomography;2024-08-09

5. Atherosclerotic cardiovascular disease in aging and the role of advanced cardiovascular imaging;npj Cardiovascular Health;2024-08-02